All Sauce from Weekly Sauce:

A rash of gasoline-related poisoning calls has led U.S. poison experts to warn against gas siphoning. Gasoline hoarding and siphoning in some East Coast states has led to a significant increase in gasoline-related emergencies, the Association of Poison Control Centers said. Recent concerns about limited gasoline supplies due to the shutdown of a major pipeline…  read on >  read on >

A U.S. presidential election can be hard on your heart. That’s the takeaway from two new studies that look back on the 2016 race between Republican Donald Trump and Democrat Hillary Clinton. For one, researchers investigated heart rhythm disorders in more than 2,400 adults in North Carolina (average age: 70.8 years) who had implanted defibrillators…  read on >  read on >

FRIDAY, May 21, 2021 (American Heart Association News) — Hispanic adults who experience perceived discrimination are more likely to have changes in the structure of their heart that may lead to cardiovascular disease, according to new research. In the past, scientists have uncovered possible links between discrimination and cardiovascular disease, including higher blood pressure in…  read on >  read on >

Vaccines approved for use in the United States and Europe show protection against all of the more infectious coronavirus variants known to be circling the globe, the World Health Organization said Thursday. “All COVID-19 virus variants can be controlled in the same way, with public health and social measures,” European Regional Director Hans Kluge said…  read on >  read on >

Mom always said too much TV would rot your brain, and as with so many other things it appears she was right. Middle-aged folks who regularly turn to TV for entertainment appear to have a greater risk of decline in their reasoning and memory later in life, three new studies suggest. Researchers found that even…  read on >  read on >

A pill called upadacitinib, already approved for treating rheumatoid arthritis, might also ease another common immunological condition — eczema. In two phase 3 clinical trials, patients with moderate to severe eczema showed rapid and significant improvements after taking the drug, said researchers at Mount Sinai in New York City. The clinical trials were funded by…  read on >  read on >